Discontinuation report MYLAN-BUPRENORPHINE/NALOXONE
| Report ID | 94048 |
| Drug Identification Number | 02408104 |
| Brand name | MYLAN-BUPRENORPHINE/NALOXONE |
| Common or Proper name | BUPRENORPHINE/NALOXONE |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | BUPRENORPHINE NALOXONE |
| Strength(s) | 8MG 2MG |
| Dosage form(s) | TABLET |
| Route of administration | SUBLINGUAL |
| Packaging size | 100BT |
| ATC code | N07BC |
| ATC description | DRUGS USED IN ADDICTIVE DISORDERS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2019-09-17 |
| Actual discontinuation date | 2019-09-17 |
| Remaining supply date | 2019-09-17 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | Discontinued in Shortage ID 3089. Last lot 3085363 exp 2019-05-31 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2019-09-18 | English | Compare |
| v2 | 2019-09-17 | French | Compare |
| v1 | 2019-09-17 | English | Compare |
Showing 1 to 3 of 3